← Leaderboards
Eva S. Liu
Brigham And Women'S Hospital
$2,877,569
Attributed
$2,877,569
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,583,971 · 5
By mechanism
R01$1,871,974 · 1
P30$706,402 · 1
K08$698,641 · 1
R03$179,000 · 1
F32$127,954 · 1
Top collaborators
- Mary L Bouxsein1 shared
- Paola Pajevic Divieti1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Rulla M Tamimi$15,389,173
- David Evan Leaf$10,646,805
- Ravi Thadhani$43,973,148
- Eric N Taylor$9,679,902
- Martha M Murray$11,108,579
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeAffectHypophosphatemiaMineralizationBlocking AntibodiesSignal TransductionProductionMolecularSerumDihydroxycholecalciferolsMouse ModelBoneInvestigationCellsSignal PathwayInheritedRicketsBone DiseasesAblationPathway InteractionsChondrocytesVitamin D3 ReceptorTendon StructureDesign
Grant awards (16)
Center for Musculoskeletal Research$706,402
P30 · FY2025 · AR · contact PI
Development of enthesopathy in the mouse model of X-linked hypophosphatemia$364,900
R01 · FY2025 · AR · contact PI
Development of enthesopathy in the mouse model of X-linked hypophosphatemia$364,900
R01 · FY2024 · AR · contact PI
Development of enthesopathy in the mouse model of X-linked hypophosphatemia$376,185
R01 · FY2023 · AR · contact PI
Development of enthesopathy in the mouse model of X-linked hypophosphatemia$372,424
R01 · FY2022 · AR · contact PI
Development of enthesopathy in the mouse model of X-linked hypophosphatemia$393,565
R01 · FY2021 · AR · contact PI
Molecular and cellular determinants of enthesopathy in X-linked hypophosphatemia$141,750
K08 · FY2019 · AR · contact PI
The role of 1,25 dihydroxyvitamin D in osteocyte perilacunar and canalicular remodeling$89,500
R03 · FY2019 · AR · contact PI
Molecular and cellular determinants of enthesopathy in X-linked hypophosphatemia$141,750
K08 · FY2018 · AR · contact PI
The role of 1,25 dihydroxyvitamin D in osteocyte perilacunar and canalicular remodeling$89,500
R03 · FY2018 · AR · contact PI
Molecular and cellular determinants of enthesopathy in X-linked hypophosphatemia$691
K08 · FY2018 · AR · contact PI
Molecular and cellular determinants of enthesopathy in X-linked hypophosphatemia$141,750
K08 · FY2017 · AR · contact PI
Molecular and cellular determinants of enthesopathy in X-linked hypophosphatemia$141,750
K08 · FY2016 · AR · contact PI
Molecular and cellular determinants of enthesopathy in X-linked hypophosphatemia$130,950
K08 · FY2015 · AR · contact PI
Comparative effectiveness of therapeutic modalities in X-linked hypophosphatemia$65,822
F32 · FY2014 · AR · contact PI
Comparative effectiveness of therapeutic modalities in X-linked hypophosphatemia$62,132
F32 · FY2013 · AR · contact PI